Literature DB >> 15310467

Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.

Masanobu Kinomoto1, Tetsu Mukai, Yong-Gang Li, Yukie Iwabu, Jiranan Warachit, J Alejandro Palacios, Madiha S Ibrahim, Shoutaro Tsuji, Toshiyuki Goto, Kazuyoshi Ikuta.   

Abstract

The infection and subsequent replication rates of human immunodeficiency virus type 1 (HIV-1) affect the pathogenicity. The initial stage of HIV-1 infection is largely regulated by viral envelope sequence. We previously reported that the defective doughnut-shaped particles produced from a persistently infected cell clone, named L-2, obtained from human CD4+ T-cell line MT-4 that was persistently infected with HIV-1 LAI strain, efficiently form particle-mediated syncytia with uninfected human CD4+ T-cell line, MOLT-4. Here, we prepared a molecular clone (pL2) containing the L-2 provirus to characterize the viral genetic region contributing to this activity to form particle-mediated syncytia. Several recombinants were constructed with pNL4-3 by replacing the pL2-derived region including full-length env. Characterization of the particles obtained by transfection with these recombinant clones confirmed that pL2-derived env carried the particle-mediated syncytia formation activity. It is noteworthy that the pL2-derived env region could also contribute to enhancement of infectivity in CD4+ T-cell lines as well as primary peripheral blood mononuclear cells (PBMCs). Thus, the HIV-1 particle-mediated syncytium formation activity could also contribute to the enhancement of HIV-1 infectivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15310467     DOI: 10.1016/j.micinf.2004.05.003

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  2 in total

1.  Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor.

Authors:  Masanobu Kinomoto; Masaru Yokoyama; Hironori Sato; Asato Kojima; Takeshi Kurata; Kazuyoshi Ikuta; Tetsutaro Sata; Kenzo Tokunaga
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  An HIV/AIDS Prophylactic vaccine is possible.

Authors:  Qiu Zhong; Ronald B Luftig
Journal:  J Immune Based Ther Vaccines       Date:  2007-12-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.